Diagnostic Tools for Onchocerciasis Elimination Programs

Trends in Parasitology

Volumn 31, Issue 11, 2015, Pages 571-582

  Vlaminck, Johnny ^a   Fischer, Peter U ^a   Weil, Gary J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DIETHYLCARBAMAZINE; IVERMECTIN;

AFRICA SOUTH OF THE SAHARA; CLINICAL EXAMINATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; ONCHOCERCIASIS; PATCH TEST; REVIEW; ANIMAL; DIAGNOSTIC PROCEDURE; DISEASE ERADICATION; STANDARDS; TRENDS;

AFRICA SOUTH OF THE SAHARA; ANIMALS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DISEASE ERADICATION; HUMANS; ONCHOCERCIASIS;

EID: 84946488374     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.06.007     Document Type: Review

References (89)

1. Little M.P., et al. Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet 2004, 363:1514-1521.
2. Walker M., et al. Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality. PLoS Negl. Trop. Dis. 2012, 6:e1578.
3. Plaisier A.P., et al. The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta trop. 1991, 48:271-284.
4. Evans D.S., et al. Status of onchocerciasis transmission after more than a decade of mass drug administration for onchocerciasis and lymphatic filariasis elimination in central Nigeria: challenges in coordinating the stop MDA decision. PLoS Negl. Trop. Dis. 2014, 8:e3113.
5. Higazi T.B., et al. Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan. Am. J. Trop. Med. Hyg. 2013, 89:51-57.
6. Coffeng L.E., et al. African programme for onchocerciasis control 1995-2015: updated health impact estimates based on new disability weights. PLoS Negl. Trop. Dis. 2014, 8:e2759.
7. Convit J., et al. Interruption of Onchocerca volvulus transmission in Northern Venezuela. Parasit. Vectors 2013, 6:289.
8. Diawara L., et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl. Trop. Dis. 2009, 3:e497.
9. Winnen M., et al. Can ivermectin mass treatments eliminate onchocerciasis in Africa?. Bull. World Health Organ. 2002, 80:384-391.
10. Lakwo T.L., et al. The disappearance of onchocerciasis from the Itwara focus, western Uganda after elimination of the vector Simulium neavei and 19 years of annual ivermectin treatments. Acta Trop. 2013, 126:218-221.
11. Traore M.O., et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl. Trop. Dis. 2012, 6:e1825.
12. Mackenzie C.D., et al. Elimination of onchocerciasis from Africa: possible?. Trends Parasitol. 2012, 28:16-22.
13. Murdoch M.E., et al. Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa. Ann. Trop. Med. Parasitol. 2002, 96:283-296.
14. Coffeng L.E., et al. Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl. Trop. Dis. 2013, 7:e2168.
15. Zouré H.G., et al. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected. Parasit. Vectors 2014, 7:326.
16. Mand S., et al. Frequent detection of worm movements in onchocercal nodules by ultrasonography. Filaria J. 2005, 4:1.
17. Albiez E.J., et al. Studies on nodules and adult Onchocerca volvulus during a nodulectomy trial in hyperendemic villages in Liberia and Upper Volta. II. Comparison of the macrofilaria population in adult nodule carriers. Tropenmed. Parasitol. 1984, 35:163-166.
18. Albiez E.J., et al. Diagnosis and extirpation of nodules in human onchocerciasis. Trop. Med. Parasitol. 1988, 39(Suppl. 4):331-346.
19. Schlie-Guzman M.A., Rivas-Alcala A.R. Antigen detection in onchocerciasis: correlation with worm burden. Trop. Med. Parasitol. 1989, 40:47-50.
20. Abanobi O.C., et al. Validity of leopard skin manifestation in community diagnosis of human onchocerciasis infection. Appl. Parasitol. 1994, 35:8-11.
21. Duerr H.P., et al. Diagnostic value of nodule palpation in onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 2008, 102:148-154.
22. Noma M., et al. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment. Parasit. Vectors 2014, 7:325.
23. Leichsenring M., et al. Ultrasonographical investigations of onchocerciasis in Liberia. Am. J. Trop. Med. Hyg. 1990, 43:380-385.
24. Franchini D., et al. Image diagnosis of zoonotic onchocercosis by Onchocerca lupi. Vet. Parasitol. 2014, 203:91-95.
25. Collins R.C., et al. Parasitological diagnosis of onchocerciasis: comparisons of incubation media and incubation times for skin snips. Am. J. Trop. Med. Hyg. 1980, 29:35-41.
26. Fink D.L., et al. Toward molecular parasitologic diagnosis: enhanced diagnostic sensitivity for filarial infections in mobile populations. J. Clin. Microbiol. 2011, 49:42-47.
27. Zimmerman P.A., et al. Polymerase chain reaction-based diagnosis of Onchocerca volvulus infection: improved detection of patients with onchocerciasis. J. Infect. Dis. 1994, 169:686-689.
28. Vincent J.A., et al. A comparison of newer tests for the diagnosis of onchocerciasis. Ann. Trop. Med. Parasitol. 2000, 94:253-258.
29. Toe L., et al. Detection of Onchocerca volvulus infection by O-150 polymerase chain reaction analysis of skin scratches. J. Infect. Dis. 1998, 178:282-285.
30. Bradley J.E., Unnasch T.R. Molecular approaches to the diagnosis of onchocerciasis. Adv. Parasitol. 1996, 37:57-106.
31. Pischke S., et al. An internal control for the detection of Onchocerca volvulus DNA by PCR-ELISA and rapid detection of specific PCR products by DNA detection test strips. Trop. Med. Int. Health 2002, 7:526-531.
32. Nutman T.B., et al. A universally applicable diagnostic approach to filarial and other infections. Parasitol. Today 1994, 10:239-243.
33. Zhang S., et al. Paper chromatography hybridization: a rapid method for detection of Onchocerca volvulus DNA amplified by PCR. Am. J. Trop. Med. Hyg. 2000, 63:85-89.
34. Alhassan A., et al. A simple isothermal DNA amplification method to screen black flies for Onchocerca volvulus infection. PLoS ONE 2014, 9:e108927.
35. Lloyd M.M., et al. Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes. Acta Trop. 2015, 146:114-118.
36. Stingl P., et al. A diagnostic 'patch test' for onchocerciasis using topical diethylcarbamazine. Trans. R. Soc. Trop. Med. Hyg. 1984, 78:254-258.
37. Newland H.S., et al. The use of diethylcarbamazine cream in the diagnosis of onchocerciasis. Trop. Med. Parasitol. 1987, 38:143-144.
38. Toe L., et al. Topical application of diethylcarbamazine to detect onchocerciasis recrudescence in west Africa. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:519-525.
39. Boatin B.A., et al. Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology 2002, 125:545-552.
40. Ozoh G., et al. Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop. Med. Int. Health 2007, 12:123-129.
41. Boussinesq M., et al. Evaluation du patch à la DEC chez les sujets infectés par Loa loa 1998, Document du Laboratoire Mixte CPC/ORSTOM d'Epidémioloie et de Santé publique No. 98-16, Centre Pasteur, Yaounde, Cameroon.
42. Guevara A.G., et al. Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution. Am. J. Trop. Med. Hyg. 2003, 68:222-227.
43. Marchon-Silva V., et al. Detection of Onchocerca volvulus (Nematoda: Onchocercidae) infection in vectors from Amazonian Brazil following mass Mectizan distribution. Mem. Inst. Oswaldo Cruz 2007, 102:197-202.
44. Rodriguez-Perez M.A., et al. Rapid suppression of Onchocerca volvulus transmission in two communities of the Southern Chiapas focus, Mexico, achieved by quarterly treatments with Mectizan. Am. J. Trop. Med. Hyg. 2008, 79:239-244.
45. Lovato R., et al. Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution. PLoS Negl. Trop. Dis. 2014, 8:e2821.
46. Toe L.D., et al. Optimization of the Esperanza window trap for the collection of the African onchocerciasis vector Simulium damnosum sensu lato. Acta Trop. 2014, 137:39-43.
47. Rodriguez-Perez M.A., et al. Development of a novel trap for the collection of black flies of the Simulium ochraceum complex. PLoS ONE 2013, 8:e76814.
48. Young R.M., et al. Identification of human semiochemicals attractive to the major vectors of onchocerciasis. PLoS Negl. Trop. Dis. 2015, 9:e3450.
49. Harnett W., et al. Molecular and immunodiagnosis of human filarial nematode infections. Parasitology 1998, 117(Suppl.):S59-S71.
50. Lavebratt C., et al. A simple dot blot assay adaptable for field use in the diagnosis of onchocerciasis: preparation of an adult worm antigen fraction which enhances sensitivity and specificity. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:303-306.
51. Weil G.J., et al. IgG4 subclass antibody serology for onchocerciasis. J. Infect. Dis. 1990, 161:549-554.
52. Bradley J.E., et al. A sensitive serodiagnostic test for onchocerciasis using a cocktail of recombinant antigens. Am. J. Trop. Med. Hyg. 1993, 48:198-204.
53. Nde P.N., et al. Sensitive and specific serodiagnosis of onchocerciasis with recombinant hybrid proteins. Am. J. Trop. Med. Hyg. 2002, 66:566-571.
54. Rodriguez-Perez M.A., et al. Antibody detection tests for Onchocerca volvulus: comparison of the sensitivity of a cocktail of recombinant antigens used in the indirect enzyme-linked immunosorbent assay with a rapid-format antibody card test. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:539-541.
55. Burbelo P.D., et al. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl. Trop. Dis. 2009, 3:e438.
56. Lobos E., et al. Identification of an Onchocerca volvulus cDNA encoding a low-molecular-weight antigen uniquely recognized by onchocerciasis patient sera. Mol. Biochem. Parasitol. 1990, 39:135-145.
57. Lobos E., et al. An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection. Science 1991, 251:1603-1605.
58. Lipner E.M., et al. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J. Infect. Dis. 2006, 194:216-221.
59. Weil G.J., et al. A rapid-format antibody card test for diagnosis of onchocerciasis. J. Infect. Dis. 2000, 182:1796-1799.
60. Oguttu D., et al. Serosurveillance to monitor onchocerciasis elimination: the Ugandan experience. Am. J. Trop. Med. Hyg. 2014, 90:339-345.
61. Katabarwa M., et al. Transmission of Onchocerca volvulus by Simulium neavei in Mount Elgon focus of Eastern Uganda has been interrupted. Am. J. Trop. Med. Hyg. 2014, 90:1159-1166.
62. Golden A., et al. Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools. PLoS ONE 2013, 8:e69231.
63. Weil G.J., et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am. J. Trop. Med. Hyg. 2013, 89:11-15.
64. Weil G.J., et al. The ICT filariasis test: a rapid-format antigen test for diagnosis of Bancroftian filariasis. Parasitol. Today 1997, 13:401-404.
65. Weil G.J. Dirofilaria immitis: identification and partial characterization of parasite antigens in the serum of infected dogs. Exp. Parasitol. 1987, 64:244-251.
66. More S.J., Copeman D.B. A highly specific and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in Bancroftian filariasis. Trop. Med. Parasitol. 1990, 41:403-406.
67. Harnett W., et al. Association between circulating antigen and parasite load in a model filarial system, Acanthocheilonema viteae in jirds. Parasitology 1990, 101:435-444.
68. Weil G.J., et al. Circulating parasite antigen in Brugia pahangi-infected jirds. J. Parasitol. 1990, 76:78-84.
69. Weil G.J., et al. Detection of circulating parasite antigens in canine dirofilariasis by counterimmunoelectrophoresis. Am. J. Trop. Med. Hyg. 1984, 33:425-430.
70. Chesnais C.B., et al. Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen. Am. J. Trop. Med. Hyg. 2013, 89:916-918.
71. Wembe F.E., et al. Development of an antigen detection dot blot assay for the diagnosis of human onchocerciasis based on the biotin-avidin binding system. Bull. Soc. Pathol. Exot. 2005, 98:177-181.
72. Eberhard M.L., et al. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. Am. J. Trop. Med. Hyg. 1997, 57:483-486.
73. Genchi C., et al. Efficacy of moxidectin for the prevention of adult heartworm (Dirofilaria immitis) infection in dogs. Parassitologia 2001, 43:139-141.
74. Genchi C., et al. Full season efficacy of moxidectin microsphere sustained release formulation for the prevention of heartworm (Dirofilaria immitis) infection in dogs. Vet. Parasitol. 2002, 110:85-91.
75. Weil G.J., et al. Changes in circulating parasite antigen levels after treatment of Bancroftian filariasis with diethylcarbamazine and ivermectin. J. Infect. Dis. 1991, 164:814-816.
76. Globisch D., et al. Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4218-4223.
77. Chandrashekar R., et al. Molecular characterization of a parasite antigen in sera from onchocerciasis patients that is immunologically cross-reactive with human keratin. J. Infect. Dis. 1995, 171:1586-1592.
78. Tritten L., et al. Detection of circulating parasite-derived microRNAs in filarial infections. PLoS Negl. Trop. Dis. 2014, 8:e2971.
79. Molyneux D.H. Filaria control and elimination: diagnostic, monitoring and surveillance needs. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:338-341.
80. Solomon A.W., et al. A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles. PLoS Negl. Trop. Dis. 2012, 6:e1746.
81. McCarthy J.S., et al. A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes. PLoS Negl. Trop. Dis. 2012, 6:e1601.
82. Katabarwa M.N., et al. Does onchocerciasis transmission take place in hypoendemic areas? a study from the North Region of Cameroon. Trop. Med. Int. Health 2010, 15:645-652.
83. Zouré H.G., et al. The geographic distribution of Loa loa in Africa: Results of large-scale implementation of the rapid assessment procedure for loiasis (RAPLOA). PLoS Negl. Trop. Dis. 2011, 5:e1210.
84. Ramzy R.M., et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on Bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006, 367:992-999.
85. Rao R.U., et al. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration. PLoS Negl. Trop. Dis. 2014, 8:e3281.
86. Weil G.J., et al. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on Bancroftian filariasis in Papua New Guinea. PLoS Negl. Trop. Dis. 2008, 2:e344.
87. Chu B.K., et al. Pilot assessment of soil-transmitted helminthiasis in the context of transmission assessment surveys for lymphatic filariasis in Benin and Tonga. PLoS Negl. Trop. Dis. 2014, 8:e2708.
88. Gunawardena S., et al. Integrated school-based surveillance for soil-transmitted helminth infections and lymphatic filariasis in Gampaha district, Sri Lanka. Am. J. Trop. Med. Hyg. 2014, 90:661-666.
89. Linehan M., et al. Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale. Am. J. Trop. Med. Hyg. 2011, 84:5-14.